Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial - Harter, Philipp; Marme, Frederik; Redondo, Andres; Reuss, Alexander; Lindemann, Kristina; Kurzeder, Christian; Van Nieuwenhuysen, Els; Marth, Christian; Pietzner, Klaus; Ray-Coquard, Isabelle; Garcia-Duran, Carmen; Jonuskiene, Goda; et al. (Journal Of Clinical Oncology, 2026)